ABIVAX revenue and financials
In the fiscal year ended December 2025, ABIVAX reported revenue of €4.57M (−63.22% year over year). The net loss was €336.1M.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- −63.22%
- 2025 vs 2024
- Net margin
- -7,354.5%
- 2024: -1,418.3%
How ABIVAX is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 218.2% a year on average over the last 5 years
Compound annual growth rate: from €14K in 2020 to €4.57M in 2025.
Operating margin fell from −1,136.6% to −5,384.1%
Operating income over revenue, 2022 → 2025: 4,247.5 percentage points.
Shares outstanding up 385.1% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.6 | 12.4 | 4.6 | 4.5 | 4.2 | 0.0 | -0.0 | 0.8 | 0.4 | 0.2 |
| Cost of revenue | — | — | — | 50.8 | 45.5 | 33.8 | 28.2 | 15.4 | 10.5 | 14.6 |
| Gross profit | 4.6 | 12.4 | 4.6 | 4.5 | 4.2 | -33.8 | -28.2 | -14.6 | -10.1 | -14.5 |
| Selling, general and administrative | 72.9 | 38.9 | 28.8 | 7.5 | 5.6 | 5.6 | 4.9 | 4.3 | 3.8 | 3.6 |
| Research and development | 178 | 147 | 103 | 48.3 | 47.8 | — | — | — | — | — |
| Operating income | -246 | -173 | -127 | -51.2 | -49.1 | -39.6 | -33.3 | -19.1 | -14.2 | -18.2 |
| EBIT | -246 | -173 | -127 | -51.2 | -49.1 | -39.6 | -33.3 | -19.1 | -14.2 | -18.2 |
| EBITDA | -245 | -172 | -127 | -50.7 | -49.1 | -39.5 | -33.2 | -19.0 | -14.1 | -18.2 |
| Interest expense | 28.5 | 12.4 | 13.8 | 6.9 | 3.6 | 2.3 | 1.6 | 0.5 | 0.0 | 0.0 |
| Pre-tax income | -330 | -176 | -148 | -60.7 | -42.5 | -40.1 | -34.9 | -19.8 | -13.9 | -17.8 |
| Income tax | 5.8 | 0.0 | 0.0 | 0.0 | — | -2.6 | -4.3 | -4.0 | -2.7 | -3.5 |
| Net income | -336 | -176 | -148 | -60.7 | -42.5 | -37.6 | -30.6 | -15.8 | -11.2 | -14.3 |
| Net income to common shareholders | -336 | -176 | -148 | -60.7 | -42.5 | -37.6 | -30.6 | -15.8 | -11.2 | -14.3 |
| Basic EPS | -4.83 | -2.80 | -3.43 | -3.18 | -2.75 | -2.62 | -2.51 | -1.55 | -1.13 | -1.47 |
| Diluted EPS | -4.83 | -2.80 | -3.43 | -3.18 | -2.75 | -2.62 | -2.51 | -1.55 | -1.13 | -1.47 |
| Average shares (basic) | 69.5 | 63.0 | 43.1 | 19.1 | 15.5 | 14.3 | 12.2 | 10.2 | 9.9 | 9.7 |
| Average shares (diluted) | 69.5 | 63.0 | 43.1 | 19.1 | 15.5 | 14.3 | 12.2 | 10.2 | 9.9 | 9.7 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.0 | 1.3 | 1.9 | 0.6 | 1.0 | 1.0 | 4.3 | 1.4 | 5.6 | 1.2 | 1.2 | 1.2 |
| Gross profit | 1.0 | 1.3 | 1.9 | 0.6 | 1.0 | 1.0 | 4.3 | 1.4 | 5.6 | 1.2 | 1.2 | 1.2 |
| Selling, general and administrative | 27.0 | 8.0 | 27.7 | 27.3 | 8.9 | 8.9 | 10.3 | 8.2 | 12.0 | 10.1 | 11.0 | 11.0 |
| Research and development | 58.3 | 49.5 | 44.4 | 55.4 | 38.6 | 39.3 | 38.6 | 43.3 | 28.9 | 35.7 | 35.3 | 35.3 |
| Operating income | -84.1 | -56.2 | -71.6 | -80.7 | -46.5 | -47.2 | -44.6 | -50.2 | -35.3 | -44.7 | -45.0 | -45.0 |
| EBIT | -84.1 | -56.2 | -71.6 | -80.7 | -46.5 | -47.2 | -44.6 | -50.2 | -35.3 | -44.7 | -45.0 | -45.0 |
| EBITDA | -84.0 | -56.1 | -70.8 | -80.6 | -46.5 | -47.1 | -43.7 | -50.1 | -35.2 | -44.6 | -44.7 | -44.7 |
| Interest expense | 0.7 | 2.5 | 15.3 | 4.2 | 3.5 | 4.5 | 1.4 | 4.7 | 3.8 | 2.4 | 2.3 | 2.3 |
| Pre-tax income | -124 | -48.2 | -76.1 | -153 | -48.4 | -52.4 | -39.4 | -55.2 | -38.8 | -42.9 | -47.9 | -47.9 |
| Income tax | -6.1 | 0.2 | 5.8 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| Net income | -117 | -48.5 | -82.0 | -153 | -48.4 | -52.4 | -39.4 | -55.2 | -38.8 | -42.9 | -47.9 | -47.9 |
| Net income to common shareholders | -117 | -48.5 | -82.0 | -153 | -48.4 | -52.4 | -39.4 | -55.2 | -38.8 | -42.9 | -47.9 | -47.9 |
| Basic EPS | -1.47 | -0.61 | -1.05 | -2.10 | -0.76 | -0.83 | -0.62 | -0.87 | -0.62 | -0.68 | -0.95 | -0.95 |
| Diluted EPS | -1.47 | -0.61 | -1.05 | -2.10 | -0.76 | -0.83 | -0.62 | -0.87 | -0.62 | -0.68 | -0.95 | -0.95 |
| Average shares (basic) | 79.6 | 79.0 | 78.2 | 72.9 | 63.4 | 63.4 | 63.1 | 63.2 | 62.9 | 62.9 | 50.2 | 50.2 |
| Average shares (diluted) | 79.6 | 79.0 | 78.2 | 72.9 | 63.4 | 63.4 | 63.1 | 63.2 | 62.9 | 62.9 | 50.2 | 50.2 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 584 | 205 | 327 | 75.5 | 109 | 71.3 | 51.7 | 54.0 | 53.8 | 60.6 |
| Current assets | 551 | 171 | 286 | 36.2 | 75.5 | 37.7 | 18.2 | 21.0 | 20.9 | 27.8 |
| Cash and equivalents | 517 | 144 | 252 | 27.0 | 60.7 | 29.3 | 9.8 | 8.0 | 1.9 | 7.9 |
| Short-term investments | 13.7 | 0.1 | 9.2 | 0.0 | — | 0.0 | 0.0 | 5.0 | 15.2 | 15.1 |
| Receivables | 10.5 | 15.7 | 19.1 | 8.3 | 8.3 | 8.0 | 8.1 | 7.8 | 3.6 | 4.8 |
| Inventory | — | — | — | — | 4.0 | — | — | — | — | — |
| Net property, plant and equipment | 2.1 | 2.7 | 0.9 | 1.6 | 0.3 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 |
| Goodwill | 18.4 | 18.4 | 18.4 | 18.4 | 32.0 | 32.0 | 32.0 | 32.0 | 32.0 | 32.0 |
| Other intangible assets | 6.6 | 6.6 | 6.6 | 6.6 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.1 | 0.1 | 0.0 | — | — | — | — | 0.7 | — |
| Current liabilities | 63.0 | 94.0 | 90.7 | 51.5 | 32.3 | 19.4 | 12.4 | 8.5 | 5.4 | 3.5 |
| Accounts payable | 37.5 | 43.8 | 47.2 | 15.5 | 18.6 | 17.4 | 10.5 | 6.7 | 4.2 | 2.6 |
| Long-term debt | 30.2 | 64.0 | 39.5 | 14.8 | 40.3 | 34.0 | 20.7 | 10.9 | — | 0.3 |
| Total debt | 32.1 | 109 | 74.5 | 49.2 | 51.7 | 34.0 | 20.7 | 10.9 | — | 0.3 |
| Total liabilities | 129 | 165 | 131 | 68.4 | 83.3 | 53.4 | 33.1 | 19.4 | 5.6 | 3.9 |
| Total equity (incl. minority) | 455 | 40.6 | 196 | 7.2 | 25.9 | 17.9 | 18.6 | 34.7 | 48.2 | 56.7 |
| Retained earnings | -738 | -439 | -283 | -144 | -81.8 | -37.6 | -93.0 | -62.4 | -46.6 | -35.4 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 462 | 547 | 584 | 652 | 120 | 167 | 205 | — | 284 | — | 327 | 327 |
| Current assets | 428 | 513 | 551 | 619 | 86.1 | 133 | 171 | — | 243 | — | 286 | 286 |
| Cash and equivalents | 388 | 477 | 517 | 590 | 60.9 | 104 | 144 | — | 222 | — | 252 | 252 |
| Short-term investments | 14.4 | 14.1 | 13.7 | — | — | — | 0.1 | — | — | — | 9.2 | 9.2 |
| Receivables | 12.9 | 10.8 | 10.5 | 19.7 | 14.7 | 18.7 | 15.7 | — | 16.4 | — | 19.1 | 19.1 |
| Net property, plant and equipment | 1.5 | 1.8 | 2.1 | 1.9 | 2.2 | 2.4 | 2.7 | — | 2.6 | — | 0.9 | 0.9 |
| Goodwill | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | — | 18.4 | — | 18.4 | 18.4 |
| Other intangible assets | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 | — | 6.6 | — | 6.6 | 6.6 |
| Long-term investments | — | — | 0.0 | 0.1 | 0.1 | 0.1 | — | — | — | — | — | — |
| Current liabilities | 71.7 | 62.2 | 63.0 | 78.8 | 112 | 106 | 94.0 | — | 80.0 | — | 90.7 | 90.7 |
| Accounts payable | 39.0 | 29.5 | 37.5 | 30.0 | 57.5 | 56.5 | 43.8 | — | 30.6 | — | 47.2 | 47.2 |
| Long-term debt | — | 32.8 | 30.2 | 44.0 | 48.9 | 61.0 | 64.0 | — | 73.6 | — | 39.5 | 39.5 |
| Total debt | 1.2 | 34.2 | 32.1 | 74.0 | 98.7 | 107 | 109 | — | 113 | — | — | — |
| Total liabilities | 95.9 | 118 | 129 | 141 | 168 | 174 | 165 | — | 158 | — | 131 | 131 |
| Total equity (incl. minority) | 366 | 430 | 455 | 511 | -48.3 | -6.6 | 40.6 | — | 126 | 196 | 196 | 196 |
| Retained earnings | -865 | -764 | -738 | -670 | -529 | -487 | -439 | — | -353 | — | -283 | -283 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -161 | -154 | -97.1 | -53.9 | -45.0 | -29.8 | -27.5 | -14.6 | -8.4 | -15.6 |
| Depreciation and amortization | 1.1 | 1.1 | 0.7 | 0.5 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | -0.0 |
| Capital expenditure | -0.1 | -0.6 | -0.3 | -0.3 | -0.0 | -0.9 | -0.9 | -0.8 | -1.0 | -0.7 |
| Investing cash flow | -8.2 | 15.8 | -8.1 | -12.0 | -6.2 | -0.6 | -0.4 | -0.3 | -0.1 | -0.1 |
| Financing cash flow | 547 | 28.2 | 335 | 32.2 | 82.7 | 49.9 | 24.6 | 10.8 | 2.6 | -0.4 |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — |
| Debt issued | 0.0 | 47.9 | 55.8 | 0.0 | 24.9 | 26.9 | 12.0 | 10.3 | 2.1 | 0.0 |
| Debt repaid | -59.5 | -13.2 | -40.7 | -9.8 | -5.9 | -3.4 | -1.1 | -0.2 | -0.1 | -0.5 |
| Effect of exchange rates | -10.3 | 2.4 | -5.1 | 0.0 | — | — | — | — | — | — |
| Net change in cash | 372 | -108 | 225 | -33.8 | 31.4 | 19.5 | -3.2 | -4.0 | -6.0 | -16.1 |
| Free cash flow | -161 | -155 | -97.4 | -54.2 | -45.1 | — | — | — | — | — |
| Levered free cash flow | -118 | -102 | -57.2 | -34.8 | -36.7 | -19.9 | -19.3 | -14.0 | -6.9 | -13.2 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -52.0 | -50.5 | -23.2 | -71.3 | -33.3 | -33.3 | -33.5 | -35.4 | -50.4 | -34.8 | -34.8 | -34.8 |
| Depreciation and amortization | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.2 | 0.2 | 0.2 |
| Capital expenditure | -0.1 | -0.1 | -0.1 | 0.0 | -0.0 | -0.0 | -0.1 | -0.3 | -0.2 | -0.0 | -0.1 | -0.1 |
| Investing cash flow | 1.0 | 0.5 | -12.7 | 3.3 | 0.2 | 1.1 | 0.6 | 1.7 | 11.6 | 1.9 | -3.2 | -3.2 |
| Financing cash flow | -39.3 | 0.1 | -39.6 | 603 | -8.8 | -7.8 | -5.8 | -6.3 | 19.1 | 21.2 | 109 | 109 |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | -0.1 | — | — | — | — | — |
| Debt issued | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | -0.6 | 23.9 | 24.6 | 27.9 | 27.9 |
| Debt repaid | -38.5 | -0.4 | -40.8 | -5.7 | -6.9 | -6.1 | -3.8 | -3.4 | -3.6 | -2.4 | -17.7 | -17.7 |
| Effect of exchange rates | -1.2 | 7.4 | -1.3 | -7.2 | -1.1 | -0.7 | 2.6 | -1.9 | 0.5 | 1.3 | -2.5 | -2.5 |
| Net change in cash | -89.4 | -39.3 | -73.0 | 529 | -42.6 | -40.6 | -36.2 | -41.9 | -19.3 | -10.3 | 68.8 | 68.8 |
| Free cash flow | -52.1 | -50.6 | -23.3 | -71.3 | -33.4 | -33.3 | -33.6 | -35.7 | -50.6 | -34.8 | -34.8 | -34.8 |
| Levered free cash flow | -46.9 | -15.2 | -20.1 | -71.4 | -25.0 | -19.0 | — | — | — | — | -25.4 | -11.8 |
Financial statements of similar companies
Companies in the group: same industry, similar size
